day9

AI just passed a medical licensing exam (USMLE) with a higher score than most human doctors. This tells you everything about where healthcare AI actually stands right now.
The technology is remarkable, but the deployment is complicated, and the gap between these two things is where most of the real story lives.
AI in drug discovery has moved faster than almost any prediction from years ago. For instance;
✍ Google DeepMind's AlphaFold2 mapped the structure of virtually every known protein by 2022.
✍ The first fully AI-designed drug entered Phase 2 clinical trials in 2023. By 2025, companies like Insilico Medicine, Recursion, and Exscientia already had dozens of AI-assisted compounds moving through development. The timeline from molecule identification to clinical trial has genuinely compressed in ways that will matter for patients within this decade.
In diagnostics, AI has proven excellent at specific, well-defined imaging tasks.
✅ Cancer detection in mammograms
✅ Diabetic retinopathy screening from eye scans
✅ Early pneumonia detection in chest X-rays.
In controlled conditions, AI is matching/exceeding specialist performance.
Now, the barrier to widespread deployment is REGULATORY APPROVAL, clinician acceptance, and integration with existing hospital infrastructure. These move at institutional speed regardless of how good the AI is, unfortunately.
For markets with specialist shortages, the calculus is different.
Zipline operates in Rwanda and Ghana, delivering medical supplies by drone to 2,500 health facilities using AI route optimization. Delivery time for blood products and critical medications in remote areas dropped from hours to minutes.
✨ A country with two radiologists per million people benefits dramatically from AI diagnostic tools.
✨ A community clinic 4 hours from the nearest specialist benefits dramatically from an AI triage tool that flags who needs urgent referral.
The constraint AI solves most efficiently is the one already most severe, and in much of the world, that constraint is simply not having enough trained people in the right places.
Honest note worth sitting with: AI healthcare tools trained primarily on Western patient data will underperform and potentially cause harm when deployed in different clinical contexts. The model does not know what it does not know, it will answer confidently regardless lol.
Practical task: Whether you work in healthcare, health technology, policy, or are simply a professional thinking about how AI will affect your sector, identify the single biggest bottleneck in getting the right information to the right person at the right time in your context. That specific bottleneck is where to apply AI first.
#30DaysOfAI #AIHealthcare #AI #Day9